Financial reports
20-F
2019 FY
Annual report (foreign)
30 Apr 20
40-F
2018 FY
Annual report (Canada)
13 Mar 19
20-F/A
2017 FY
Annual report (foreign) (amended)
12 Jul 18
20-F
2017 FY
Annual report (foreign)
30 Apr 18
40-F
2016 FY
Annual report (Canada)
29 Mar 17
40-F/A
2015 FY
Annual report (Canada) (amended)
1 Apr 16
40-F
2015 FY
Annual report (Canada)
29 Mar 16
40-F/A
2014 FY
Annual report (Canada) (amended)
28 Jul 15
40-F
2014 FY
Annual report (Canada)
27 Mar 15
40-F/A
2013 FY
Annual report (Canada) (amended)
30 Apr 14
Current reports
6-K
Current report (foreign)
27 May 20
6-K
Correvio Obtains Final Order for Plan of Arrangement
21 May 20
6-K
CORREVIO Announces Results from Annual GENERAL and special meeting of SECURITYHOLDERS
18 May 20
6-K
Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA
6 May 20
6-K
Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19
4 May 20
6-K
Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA
1 May 20
6-K
Current report (foreign)
17 Apr 20
6-K
Correvio Obtains Interim Order For Plan Of Arrangement
9 Apr 20
6-K
Current report (foreign)
30 Mar 20
6-K
Correvio Reports full year 2019 FINANCIAL Results
30 Mar 20
Registration and prospectus
15-12G
Securities registration termination
9 Jun 20
25-NSE
Exchange delisting
27 May 20
S-8 POS
Registration of securities for employees (post-effective amendment)
27 May 20
S-8 POS
Registration of securities for employees (post-effective amendment)
27 May 20
POS AM
Prospectus update (post-effective amendment)
27 May 20
F-10POS
Automatic registration of securities (post-effective amendment, Canada)
27 May 20
POS AM
Prospectus update (post-effective amendment)
27 May 20
SUPPL
Supplemental materials (foreign)
2 Aug 19
SUPPL
Supplemental materials (foreign)
2 Aug 19
SUPPL
Supplemental materials (foreign)
13 Mar 19
Proxies
No filings
Other
EFFECT
Notice of effectiveness
28 May 20
EFFECT
Notice of effectiveness
28 May 20
CT ORDER
Confidential treatment order
20 Aug 18
EFFECT
Notice of effectiveness
9 Jul 18
UPLOAD
Letter from SEC
5 Jan 17
CORRESP
Correspondence with SEC
22 Dec 16
CORRESP
Correspondence with SEC
21 Nov 16
UPLOAD
Letter from SEC
4 Nov 16
CORRESP
Correspondence with SEC
13 Oct 16
UPLOAD
Letter from SEC
28 Sep 16
Ownership
SC 13G/A
Klein Roger M.
26 May 20
SC 13G
Klein Roger M.
16 Apr 20
SC 13G
Correvio Pharma Corp.
24 Feb 20
SC 13G/A
Correvio Pharma Corp.
14 Feb 20
SC 13G/A
Correvio Pharma Corp.
13 Feb 20
SC 13G/A
Correvio Pharma Corp.
7 Jan 20
SC 13G/A
Correvio Pharma Corp.
4 Sep 19
SC 13G/A
Correvio Pharma Corp.
5 Apr 19
SC 13G/A
Correvio Pharma Corp.
15 Feb 19
SC 13G
Correvio Pharma Corp.
15 Feb 19